International Immunology, Vol. 13, No. 3, 367-376,
March 2001
© 2001 Japanese Society for Immunology
Comprehensive gene expression profile of human activated Th1- and Th2-polarized cells
Department of Molecular Preventive Medicine, School of Medicine and CREST, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
Correspondence to: K. Matsushima
In response to antigen stimulation, Th cells differentiate into two types of effector cells, Th1 and Th2. Th1 cells predominantly mediate cellular immunity, whereas Th2 cells induce humoral allergic responses. We have conducted here serial analysis of gene expression (SAGE) in human activated Th1- and Th2-polarized cells from cord blood. SAGE analysis of 64,510 tags (32,219 and 32,291 tags from Th1 and Th2 cells respectively) allowed identification of 22,096 different transcripts. In activated Th1 cells, many of the known genes (12 genes, P < 0.01; 56 genes, P < 0.05), including genes encoding IFN-
, lymphotactin, osteopontin, MIP-1
, MIP-1ß, perforin, ß-catenin and CD55, are highly expressed. On the other hand, in activated Th2 cells rather limited numbers of known genes (four genes, P < 0.01; 10 genes; P < 0.05), such as genes encoding FUS, ILF-2, IL-13 and E2-EPF, are found to be selectively expressed. The comprehensive identification of genes selectively expressed in human activated Th1 or Th2 cells should contribute to our understanding of the molecular basis of Th1/Th2-dominated human diseases and may provide genetic information to diagnose these diseases.
Keywords: chemokine, cytokine, serial analysis of gene expression, Th, transcripts
Transmitting editor: M. Miyasaka
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Sekiguchi, S. Kawauchi, T. Furuya, N. Inaba, K. Matsuda, S. Ando, M. Ogasawara, H. Aburatani, H. Kameda, K. Amano, et al. Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-{alpha} monoclonal antibody, infliximab Rheumatology, June 1, 2008; 47(6): 780 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. K. Mason, S. McFarlane, P. G. Johnston, P. Crowe, P. J. Erwin, M. M. Domostoj, F. C. Campbell, S. Manaviazar, K. J. Hale, and M. El-Tanani Agelastatin A: a novel inhibitor of osteopontin-mediated adhesion, invasion, and colony formation Mol. Cancer Ther., March 1, 2008; 7(3): 548 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Lund, M. Loytomaki, T. Naumanen, C. Dixon, Z. Chen, H. Ahlfors, S. Tuomela, J. Tahvanainen, J. Scheinin, T. Henttinen, et al. Genome-Wide Identification of Novel Genes Involved in Early Th1 and Th2 Cell Differentiation J. Immunol., March 15, 2007; 178(6): 3648 - 3660. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Vos, N. A. Datson, K. F. Rabe, and P. S. Hiemstra Exploring host-pathogen interactions at the epithelial surface: application of transcriptomics in lung biology Am J Physiol Lung Cell Mol Physiol, February 1, 2007; 292(2): L367 - L377. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Baron, M.-C. Meunier, E. Caron, C. Cote, M. J. Cameron, D. J. Kelvin, R. LeBlanc, V. Rineau, and C. Perreault Asynchronous Differentiation of CD8 T Cells That Recognize Dominant and Cryptic Antigens J. Immunol., December 15, 2006; 177(12): 8466 - 8475. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hahtola, S. Tuomela, L. Elo, T. Hakkinen, L. Karenko, B. Nedoszytko, H. Heikkila, U. Saarialho-Kere, J. Roszkiewicz, T. Aittokallio, et al. Th1 Response and Cytotoxicity Genes Are Down-Regulated in Cutaneous T-Cell Lymphoma. Clin. Cancer Res., August 15, 2006; 12(16): 4812 - 4821. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sodek, A. P. Batista Da Silva, and R. Zohar Osteopontin and mucosal protection. J. Dent. Res., May 1, 2006; 85(5): 404 - 415. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Vietor, R. Kurzbauer, G. Brosch, and L. A. Huber TIS7 Regulation of the {beta}-Catenin/Tcf-4 Target Gene Osteopontin (OPN) Is Histone Deacetylase-dependent J. Biol. Chem., December 2, 2005; 280(48): 39795 - 39801. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Lindstedt, A. Schiott, A. Bengtsson, K. Larsson, M. Korsgren, L. Greiff, and C. A. K. Borrebaeck Genomic and functional delineation of dendritic cells and memory T cells derived from grass pollen-allergic patients and healthy individuals Int. Immunol., April 1, 2005; 17(4): 401 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. El-Tanani, A. Platt-Higgins, P. S. Rudland, and F. C. Campbell Ets Gene PEA3 Cooperates with {beta}-Catenin-Lef-1 and c-Jun in Regulation of Osteopontin Transcription J. Biol. Chem., May 14, 2004; 279(20): 20794 - 20806. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Muller, S. Bischof, F. Sommer, M. Lohoff, W. Solbach, and T. Laskay Differential Production of Macrophage Inflammatory Protein 1{gamma} (MIP-1{gamma}), Lymphotactin, and MIP-2 by CD4+ Th Subsets Polarized In Vitro and In Vivo Infect. Immun., November 1, 2003; 71(11): 6178 - 6183. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Stievano, V. Tosello, N. Marcato, A. Rosato, A. Sebelin, L. Chieco-Bianchi, and A. Amadori CD8+{alpha}{beta}+ T Cells That Lack Surface CD5 Antigen Expression Are a Major Lymphotactin (XCL1) Source in Peripheral Blood Lymphocytes J. Immunol., November 1, 2003; 171(9): 4528 - 4538. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-i. Hashimoto, S. Nagai, J. Sese, T. Suzuki, A. Obata, T. Sato, N. Toyoda, H.-Y. Dong, M. Kurachi, T. Nagahata, et al. Gene expression profile in human leukocytes Blood, May 1, 2003; 101(9): 3509 - 3513. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Liu, R. C. McEachin, and D. J. States Computationally Identifying Novel NF-kappa B-Regulated Immune Genes in the Human Genome Genome Res., April 1, 2003; 13(4): 654 - 661. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Geiben-Lynn, M. Kursar, N. V. Brown, M. M. Addo, H. Shau, J. Lieberman, A. D. Luster, and B. D. Walker HIV-1 Antiviral Activity of Recombinant Natural Killer Cell Enhancing Factors, NKEF-A and NKEF-B, Members of the Peroxiredoxin Family J. Biol. Chem., January 10, 2003; 278(3): 1569 - 1574. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Obata-Onai, S.-i. Hashimoto, N. Onai, M. Kurachi, S. Nagai, K.-i. Shizuno, T. Nagahata, and K. Matsushima Comprehensive gene expression analysis of human NK cells and CD8+ T lymphocytes Int. Immunol., October 1, 2002; 14(10): 1085 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Dorner, A. Scheffold, M. S. Rolph, M. B. Huser, S. H. E. Kaufmann, A. Radbruch, I. E. A. Flesch, and R. A. Kroczek MIP-1alpha , MIP-1beta , RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines PNAS, April 30, 2002; 99(9): 6181 - 6186. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Koguchi, K. Kawakami, S. Kon, T. Segawa, M. Maeda, T. Uede, and A. Saito Penicillium marneffei Causes Osteopontin-Mediated Production of Interleukin-12 by Peripheral Blood Mononuclear Cells Infect. Immun., March 1, 2002; 70(3): 1042 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mazzali, T. Kipari, V. Ophascharoensuk, J.A. Wesson, R. Johnson, and J. Hughes Osteopontin--a molecule for all seasons QJM, January 1, 2002; 95(1): 3 - 13. [Full Text] [PDF] |
||||
![]() |
B. G. Dorner, A. Scheffold, M. S. Rolph, M. B. Huser, S. H. E. Kaufmann, A. Radbruch, I. E. A. Flesch, and R. A. Kroczek MIP-1alpha , MIP-1beta , RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines PNAS, April 30, 2002; 99(9): 6181 - 6186. [Abstract] [Full Text] [PDF] |
||||












